Clinical Trial Update: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada

View source ↗

Summary

Canada-based expanded-access study of oral liquid efavirenz for children with HIV infection; the study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Status: NO_LONGER_AVAILABLE